JP2012092229A5
(enExample )
2012-11-22
JP2011126894A5
(enExample )
2012-03-01
JP2016501937A5
(enExample )
2017-06-08
JP2009256615A5
(enExample )
2011-11-04
JP2014507411A5
(enExample )
2015-02-26
HRP20151263T1
(hr )
2015-12-18
Natrijeva sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
WO2011039368A3
(en )
2011-06-23
Dll4-binding molecules
JP2012097086A5
(enExample )
2013-02-07
JP2012532043A5
(enExample )
2013-08-22
JP2012517962A5
(enExample )
2013-08-15
JP2011037901A5
(enExample )
2012-01-05
JP2011078421A5
(enExample )
2012-02-23
JP2014512451A5
(enExample )
2015-06-18
WO2015011119A3
(en )
2015-05-28
Salts of dasatinib in amorphous form
JP2009531465A5
(enExample )
2009-11-05
WO2012149069A3
(en )
2015-06-11
Stable solid form agave sweeteners and methods for manufacture thereof
WO2015011120A3
(en )
2015-04-16
Salts of dasatinib in crystalline form
JP2010205731A5
(enExample )
2013-04-11
JP2015019598A5
(enExample )
2015-07-23
JP2014520848A5
(enExample )
2014-10-09
WO2012011707A3
(en )
2012-05-31
Substituted pyridinone derivatives and methods for manufacturing the same
JP2009055850A5
(enExample )
2009-05-21
WO2009047699A8
(en )
2009-05-28
An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof
JP2014520188A5
(enExample )
2015-07-23
JP2008280345A5
(enExample )
2011-04-14